Immediate Impact
57 standout
Citing Papers
Second Primary Malignancies after CAR T-Cell Therapy: A Systematic Review and Meta-analysis of 5,517 Lymphoma and Myeloma Patients
2024 Standout
A systematic review and meta-analysis of nonrelapse mortality after CAR T cell therapy
2024 Standout
Works of Subhash Varma being referenced
Randomized controlled trial of individualized, low dose, fixed duration lenalidomide maintenance versus observation after frontline chemo-immunotherapy in CLL
2021
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Subhash Varma | 184 | 85 | 62 | 168 | 107 | 61 | 620 | |
| C. G. Winearls | 66 | 75 | 40 | 97 | 136 | 33 | 738 | |
| Michael W. Henderson | 120 | 40 | 88 | 56 | 154 | 36 | 705 | |
| Ravindra Kumar | 175 | 95 | 186 | 173 | 74 | 74 | 692 | |
| Mukta Pujani | 202 | 71 | 84 | 151 | 35 | 77 | 640 | |
| Anastasia Garoufi | 53 | 77 | 56 | 154 | 47 | 65 | 661 | |
| John A. Koepke | 201 | 45 | 78 | 59 | 83 | 54 | 710 | |
| Pierre Bories | 188 | 98 | 70 | 37 | 123 | 57 | 621 | |
| Mayank Sharma | 112 | 39 | 43 | 256 | 95 | 50 | 600 | |
| Hans Dieperink | 67 | 33 | 23 | 153 | 102 | 67 | 685 | |
| N. Stathakis | 176 | 16 | 82 | 79 | 119 | 38 | 637 |
All Works
Login with ORCID to disown or claim papers
Loading papers...